Ex Vivo Responses of Plasmodium falciparum Clinical Isolates to Conventional and New Antimalarial Drugs in Niger

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2013-04-22

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1128/AAC.02383-12PMID 23612203PMCID PMC3697322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum

  2012cited by this paper
• Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study

  2012cited by this paper
• A simplified intravenous artesunate regimen for severe malaria.

  2012cited by this paper
• A refined estimate of the malaria burden in Niger

  2012cited by this paper
• Malaria plan under scrutiny

  2012cited by this paper
• In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria.

  2011cited by this paper
• The threat of artemisinin-resistant malaria.

  2011cited by this paper
• Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs

  2011cited by this paper
• In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda

  2010cited by this paper
• Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum

  2010cited by this paper
• In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in pfcrt and pfmdr1

  2009cited by this paper
• Artemisinin resistance in Plasmodium falciparum malaria.

  2009cited by this paper
• Human Development Report 2007/2008 Fighting Climate Change: Human Solidarity in a Divided World, UNDP, New York

  2009cited by this paper
• Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

  2009cited by this paper
• Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger

  2009influential reference
• Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.

  2009cited by this paper
• Field-based evidence for the linkage of pfcrt and pfdhfr drug-resistant malaria genotypes and clinical profiles of severe malaria in Niger.

  2007cited by this paper
• Pastoral livelihood adaptation to drought and institutional interventions in Kenya

  2007cited by this paper
• Artemisinin-based combination treatment of falciparum malaria.

  2007cited by this paper
• Human Development Report 2007/8. Fighting Climate Change: Human Solidarity in a Divided World

  2007cited by this paper
• Prevalence of In Vitro Resistance to Eleven Standard or New Antimalarial Drugs among Plasmodium falciparum Isolates from Pointe-Noire, Republic of the Congo

  2006cited by this paper
• Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.

  2005cited by this paper
• In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).

  2005influential reference
• World malaria report

  2005cited by this paper
• In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.

  2005cited by this paper
• Short report: lack of prediction of amodiaquine efficacy in treating Plasmodium falciparum malaria by in vitro tests.

  2004cited by this paper
• The puzzling links between malaria transmission and drug resistance.

  2003cited by this paper
• In Vitro Activities of Piperaquine and Other 4-Aminoquinolines against Clinical Isolates of Plasmodium falciparum in Cameroon

  2003cited by this paper
• Efficacy of chloroquine in the treatment of uncomplicated, Plasmodium falciparum malaria in Niamey, Niger, in 2001

  2003cited by this paper
• Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.

  2000cited by this paper
• [Chloroquine sensitivity of Plasmodium falciparum at the Gamkalley Clinic and the Nigerian armed forces PMI (Niamey, Niger)].

  1999cited by this paper
• In Vitro Activity of Lumefantrine (Benflumetol) against Clinical Isolates of Plasmodium falciparum in Yaoundé, Cameroon

  1998cited by this paper
• In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum.

  1993cited by this paper
• Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

  1979cited by this paper
• World health statistics.

  1949cited by this paper

• Increased in the Prevalence of Plasmodium Falciparum With Kelch13 C580Y Mutations and the Decline in pfcrt and pfmdr1 Mutant Alleles in Papua New Guinea

  2021cites this paper
• Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda

  2019cites this paper
• Methods for monitoring artemisinin-based combination therapies efficacy

  2017influential citation
• Influence of the pfmdr1 Gene on In Vitro Sensitivities of Piperaquine in Thai Isolates of Plasmodium falciparum.

  2017cites this paper
• Comparison of a Formulated Transport Medium and EDTA Anticoagulant in Kenyan Field Isolates from Maseno Division against a Panel of Antimalarials Using SYBR Green I technique

  2016influential citation
• In-vitro activity of artemether, lumefantrine, dihydroartemisinin and piperaquine against Plasmodium falciparum clinical isolates transported in a formulated transport medium and EDTA from Chulaimbo sub-county Hospital

  2016cites this paper
• The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine

  2015cites this paper
• Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine

  2015cites this paper
• Drying anti-malarial drugs in vitro tests to outsource SYBR green assays

  2015influential citation
• Impact of Antimalarial Treatment and Chemoprevention on the Drug Sensitivity of Malaria Parasites Isolated from Ugandan Children

  2015cites this paper
• Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite’s chloroquine resistance transporter

  2014cites this paper
• Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal

  2014influential citation
• IN VITRO SUSCEPTIBILITY OF PLASMODIUM FALCIPARUM TO LUMEFANTRINE AND ANALYSIS OF POLYMOPHYSIMS IN PFMDR-1 GENE ISOLATES FROM ABIDJAN (CÔTE D'IVOIRE)

  2014cites this paper
• Epidemiology of malaria in an area of seasonal transmission in Niger and implications for the design of a seasonal malaria chemoprevention strategy

  2013cites this paper
• In Vitro Susceptibility of 57 Isolates of Plasmodium Falciparum to Atovaquone And Lumefantrine in Abidjan

  2013cites this paper